At InfinixBio, we work with entrepreneurs, biotechnology companies, biotech incubators, and investors to advance technology to market.  Product development and commercialization are truly the energy here.  We integrate a market-driven mindset into our scientific techniques, thereby assuring our clients that all procedures and experiments are performed with their commercialization goals firmly in mind. From industries as diverse as oil & gas to food, and products ranging from cancer therapeutics to infectious disease diagnostics, our expertise is in adapting products to serve current markets, and capture new ones. 

InfinixBio has developed its own advanced technology for genetically engineering superior microbial strains and protein products that is faster and more reliable than traditional methods. Our engine features a disruptive technology that utilizes a more efficient process to create stable bacterial strains that radically lower process development and production costs.

Learn more about InfinixBio’s core capabilities by visiting our website or sending us an email.


Nick Henderson, CEO